Health Care & Life Sciences » Biotechnology | Molecular Partners AG

Molecular Partners AG

Molecular Partners AG
Stock Exchange SIX Swiss Exchange
EPS
CHF1.76
Market Cap
CHF299.38 M
Shares Outstanding
21.37 M
Public Float
10.5 M

Profile

Address
Wagistrasse 14
Zurich Zurich 8952
Switzerland
Employees -
Website http://www.molecularpartners.com
Updated 07/08/2019
Molecular Partners AG engages in the development of protein therapies for treatment of serious diseases like cancer and sight-threatening disorders. It also develops its products through its brand known as DARPins, which targets specific and potent monoclonal antibodies that offers potential to address existing limitations of antibody drugs. The company was founded by Christian Zahnd, Patrick Amstutz, Patrik Forrer, Andreas Plückthun and Michael Tobias Stumpp on November 23, 2004 and is headquartered in Zurich, Switzerland.

Financials

View All

William Matt Burns
Chairman
Patrick Amstutz
Chief Executive Officer & Director